The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal ...

La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A ...

We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.” ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically driven forms of excess weight.

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

The president will impose a baseline 10% tariff on all countries, as well as higher levies on certain nations. Pharmaceutical ...

The Swiss drugmaker, which holds European rights to Elevidys, suspended three trials while researchers investigate the death ...

Teams working on device communications and policy were cut from the agency on Tuesday, according to multiple FDA workers.

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create ...